For research use only. Not for therapeutic Use.
Diclazuril-d4 (CAS: 1632495-80-7), a premium pharmaceutical research compound designed for advanced veterinary and antiparasitic studies. As a deuterated analog of Diclazuril, it offers enhanced stability and improved pharmacokinetic properties. Diclazuril-d4 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel antiparasitic therapies for veterinary applications. Trusted by leading laboratories, Diclazuril-d4 is your go-to solution for cutting-edge antiparasitic research. Unlock new possibilities in veterinary medicine with Diclazuril-d4, where innovation meets reliability.
| Catalog Number | S000233 |
| CAS Number | 1632495-80-7 |
| Molecular Formula | C17H5D4Cl3N4O2 |
| Purity | ≥95% |
| IUPAC Name | 2-(4-chloro-2,3,5,6-tetradeuteriophenyl)-2-[2,6-dichloro-4-(3,5-dioxo-1,2,4-triazin-2-yl)phenyl]acetonitrile |
| InChI | InChI=1S/C17H9Cl3N4O2/c18-10-3-1-9(2-4-10)12(7-21)16-13(19)5-11(6-14(16)20)24-17(26)23-15(25)8-22-24/h1-6,8,12H,(H,23,25,26)/i1D,2D,3D,4D |
| InChIKey | ZSZFUDFOPOMEET-RHQRLBAQSA-N |
| SMILES | [2H]C1=C(C(=C(C(=C1C(C#N)C2=C(C=C(C=C2Cl)N3C(=O)NC(=O)C=N3)Cl)[2H])[2H])Cl)[2H] |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Diaferia, M., et al., Efficacy of toltrazuril 5 % suspension (Baycox(R), Bayer) and diclazuril (Vecoxan(R), Janssen-Cilag) in the control of Eimeria spp. in lambs. Parasitol Res, 2013. 112 Suppl 1: p. 163-8. [3]. http://www.huvepharma.com/products/view/190 |
